GlassScriptPhysician profile
Carole L Gordon
NPI 1306888334
$14,147.45
in general payments reported to CMS, 2019-2025
47 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $733 · 2021: $971 · 2022: $969 · 2023: $1,705 · 2024: $8,904 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,066 · Food and Beverage: $2,543 · Honoraria: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,066.00 |
| Food and Beverage | $2,543.22 |
| Honoraria | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $8,647.22 | 2021-2025 | Solesta, Barrigel, Urolift |
| Axonics, INC. | $1,383.31 | 2020-2024 | Axonics |
| Sumitomo Pharma America, INC. | $688.94 | 2023-2024 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $595.70 | 2019-2023 | Myrbetriq |
| Urovant Sciences INC | $274.31 | 2021-2022 | |
| Abbvie INC. | $204.08 | 2022-2024 | |
| Valencia Technologies Corporation | $187.62 | 2023-2024 | Ecoin Device Kit |
| Boston Scientific Corporation | $182.15 | 2019-2021 | |
| Pfizer INC. | $158.73 | 2019-2023 | |
| Urogen Pharma, INC. | $133.87 | 2020-2024 | Jelmyto |
| Coloplast Corp | $132.63 | 2019-2021 | |
| Medtronic USA, INC. | $126.41 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $123.42 | 2020 | |
| Srs Medical Systems, INC. | $113.91 | 2019-2021 | |
| Allergan, INC. | $110.97 | 2020-2021 |
Show all 45 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$66,817.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carole Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.